300439.SZ
美康生物
SZSE · Healthcare · C 制造业 · CN
CNY 9.23
−1.18%Margins
Gross margin
36.5%
EBITDA margin
13.3%
EBIT margin
2.4%
Net margin
4.3%
FCF margin
5.8%
2.2%
Return on equity
1.9%
Return on assets
1.2%
Return on invested capital
0.43x
Asset turnover
CNY 255.0M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026